bpc 157 for als BPC-157 – Alphaceuticals by Dr. Catherine BPC 157 (Body Protection Compound-157)

Seek urgent care for hives, swelling of the face or throat, severe dizziness, wheezing, or difficulty breathing

Muscle weakness

Treatment-Resistant Tendinopathy Patients: Individuals whose chronic tendinopathy has not responded to 6 or more months of physical therapy, corticosteroid injections, and NSAIDs are likely to explore unproven adjunct options (BPC-157)

[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings

BPC-157 has demonstrated remarkably low toxicity with no established lethal dose, and its origin from human gastric juice suggests good biological compatibility